Sbc Virbac Limited.

Hsu-Chung Gabriel Chen

Tsun-Yung Kuo

Chung-Chin Wu

Han-Ting Chen

Yu-San Chen

Shu-Hsiang Yang

The invention relates to a novel porcine circovirus type 2 (PCV2) strain. The invention also relates to immunogenic compositions containing the novel PCV2 strain, PCV2 test kits, and applications of the novel PCV2 strain.

Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof

A porcine circovirus type-2 (PCV2) immunogenic composition includes an antigenic peptide. The antigenic peptide is a non-arginine-rich peptide of a PCV2 open reading frame 2 (ORF2) and/or a recombinant fusion protein having the non-arginine-rich peptide of the PCV2 ORF2, a PE peptide, and a KDEL signal peptide. The number of arginines of the non-arginine-rich peptide of the PCV2 ORF2 is not greater than half of the number of arginines of the arginine-rich domain of the N terminal of the PCV2 ORF2.

Growing community of inventors

Taipei, Taiwan

Hsu-Chung Gabriel Chen